arrow
Return

Ocular sarcoidosis: from clinical signs to targeted interventions

delete2026-06-27
delete0
delete
OA
AI
T
Thomas El Jammal
R
Robin Jacquot
S
Stéphane Abramowicz
L
Laurent Kodjikian
T
Thibaud Mathis
Y
Yasmine Serrar
L
Lucas Séjournet
P
Pascal Sève
DOI:10.1016/j.coi.2026.102810delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• Sarcoid uveitis is a heterogeneous condition, requiring a careful and systematic diagnostic approach. • Current classification criteria improve diagnostic standardization but have important limitations (limited integration of systemic involvement, lack of therapeutic guidance). • Management relies on a stepwise strategy combining corticosteroids, conventional immunosuppressive agents, or biologics. • Emerging therapies targeting specific immune pathways, including IL-6 and JAK-STAT signaling, are reshaping the treatment landscape.

Journal

Current Opinion in Immunology cover
Current Opinion in Immunology
IF:
5.8
Papers:
3.4K
Citations:
9.5K

Organization

H
hôpital de la croix rousse
Scholars:
11
Papers: 4
Citations: 0